Patents by Inventor Chienjin Huang

Chienjin Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Yeast expressed classical swine fever virus glycoprotein E2 and use thereof
    Patent number: 9359411
    Abstract: The present invention provides a recombinant yeast system for expressing the glycoprotein E2 of classical swine fever virus (CSFV), in which the expression level of yE2 is improved by codon optimization and shortening coding region of E2 gene. The truncated E2 subunits are used as major active ingredient in anti-CSFV vaccines and useful diagnostic blocking ELISA kits for CSFV infection with easy manipulation and low cost.
    Type: Grant
    Filed: December 14, 2013
    Date of Patent: June 7, 2016
    Assignee: MAW HSING BIOTECH CO., LTD.
    Inventors: Chienjin Huang, Maw-Sheng Chien, Guang-Jan Lin
  • YEAST EXPRESSED CLASSICAL SWINE FEVER VIRUS GLYCOPROTEIN E2 AND USE THEREOF
    Publication number: 20140099338
    Abstract: The present invention provides a recombinant yeast system for expressing the glycoprotein E2 of classical swine fever virus (CSFV), in which the expression level of yE2 is improved by codon optimization and shortening coding region of E2 gene. The truncated E2 subunits are used as major active ingredient in anti-CSFV vaccines and useful diagnostic blocking ELISA kits for CSFV infection with easy manipulation and low cost.
    Type: Application
    Filed: December 14, 2013
    Publication date: April 10, 2014
    Applicant: Mao-Xing Biological Technology Co., Ltd.
    Inventors: Chienjin Huang, Maw-Sheng Chien, Guang-Jan Lin
  • YEAST EXPRESSED CLASSICAL SWINE FEVER VIRUS GLYCOPROTEIN E2 AND USE THEREOF
    Publication number: 20100028384
    Abstract: A glycoprotein E2 of classical swine fever virus (CSFV) expressed in a recombinant yeast system. The recombinant E2 protein (yE2) is able to form a homodimer, exhibits glycosylation conformation and possesses correct immunogenicity. An anti-CSFV vaccine can be provided with yE2 as a major active ingredient to induce high titers of neutralizing antibody in vaccinated pigs, and to induce a protection against CSFV infection.
    Type: Application
    Filed: July 30, 2009
    Publication date: February 4, 2010
    Applicant: MAO-XING BIOLOGICAL TECHNOLOGY CO., LTD.
    Inventors: Chienjin Huang, Maw-Sheng Chien, Guang-Jan Lin